Opportunity ID: 357488

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-25-300
Funding Opportunity Title: Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 02, 2024
Last Updated Date: Dec 02, 2024
Original Closing Date for Applications: Jan 07, 2028
Current Closing Date for Applications: Jan 07, 2028
Archive Date: Feb 12, 2028
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: County governments
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Independent school districts
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
State governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this notice of funding opportunity (NOFO) is to support the investigation of HIV-1 Envelope (Env) cell surface expression, the structural mechanism of biologic-mediated cell killing, and the development of novel approaches to enhance the recognition and elimination of Env-expressing, HIV-1 infected cells. These studies are expected to inform the development of immunotherapies and targeted vaccines for HIV-1 prevention and cure.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-25-300.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 357488 Full Announcement-PAR-25-300 -> PAR-25-300-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-I Use for due dates on or after January 25, 2025 PKG00289345 Apr 07, 2025 Jan 07, 2028 View

Package 1

Mandatory forms

357488 RR_SF424_5_0-5.0.pdf

357488 PHS398_CoverPageSupplement_5_0-5.0.pdf

357488 RR_OtherProjectInfo_1_4-1.4.pdf

357488 PerformanceSite_4_0-4.0.pdf

357488 RR_KeyPersonExpanded_4_0-4.0.pdf

357488 PHS398_ResearchPlan_5_0-5.0.pdf

357488 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

357488 RR_Budget_3_0-3.0.pdf

357488 RR_SubawardBudget30_3_0-3.0.pdf

357488 PHS398_ModularBudget_1_2-1.2.pdf

357488 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T14:27:13-05:00

Share This Post, Choose Your Platform!

About the Author: